AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 277: E439-E446, 1999;
0193-1849/99 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schuldt, S.
Right arrow Articles by Welbourne, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schuldt, S.
Right arrow Articles by Welbourne, T.
Vol. 277, Issue 3, E439-E446, September 1999

EPILOGUE
Glutamate transport asymmetry and metabolism in the functioning kidney

Scott Schuldt, Patsy Carter, and Tomas Welbourne

Department of Cellular and Molecular Physiology, Louisiana State University Medical Center, Shreveport, Louisiana 71130

Renal glutamate extraction in vivo shows a preference for the uptake of D-glutamate on the antiluminal and L-glutamate on the luminal tubule surface. To characterize this functional asymmetry, we isolated rat kidneys and perfused them with an artificial plasma solution containing either D- or L-glutamate alone or in combination with the system X-AG specific transport inhibitor, D-aspartate. To confirm that removal of glutamate represented transport into tubule cells, we monitored products formed as the result of intracellular metabolism and related these to the uptake process. Perfusion with D-glutamate alone resulted in a removal rate that equaled or exceeded the L-glutamate removal rate, with uptake predominantly across the antiluminal surface; L-glutamate uptake occurred nearly equally across both luminal and antiluminal surfaces. Thus the preferential uptake of D-glutamate at the antiluminal and L-glutamate at the luminal surface confirms the transport asymmetry observed in vivo. Equimolar D-aspartate concentration blocked most of the antiluminal D-glutamate uptake and a significant portion of the luminal L-glutamate uptake, consistent with system X-AG activity at both sites. D-Glutamate uptake was associated with 5-oxo-D-proline production, whereas L-glutamate uptake supported both glutamine and 5-oxo-L-proline formation; D-aspartate reduced production of both 5-oxoproline and glutamine. The presence of system X-AG activity on both the luminal and antiluminal tubule surfaces, exhibiting different reactivity toward L- and D-glutamate suggests that functional asymmetry may reflect two different X-AG transporter subtypes.

glutamate isomers; D-aspartate; system X-AG subtypes; excitatory amino acid transporter carrier 1; GLT1 glutamate transporter; 5-oxoproline; glutamine; ammonium


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. Raj, M. Langford, S. Krueger, M. Shelton, and T. Welbourne
Regulatory responses to an oral D-glutamate load: formation of D-pyrrolidone carboxylic acid in humans
Am J Physiol Endocrinol Metab, February 1, 2001; 280(2): E214 - E220.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Schachter and J. C. Sang
Aortic leucine-to-glutamate pathway: metabolic route and regulation of contractile responses
Am J Physiol Heart Circ Physiol, March 1, 2002; 282(3): H1135 - H1148.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online